STOCK TITAN

Exponent (EXPO) VP John Pye receives new stock options at $66.56 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Exponent Inc. vice president John Pye received new stock option awards. On April 6, 2026, he was granted an Incentive Stock Option for 6,008 shares and a Non-Qualified Stock Option for 14,992 shares, each with an exercise price of $66.56 per share.

The options become exercisable in four equal annual installments and are scheduled to expire on April 6, 2036. These awards are compensation-related grants, not open-market purchases or sales, and increase his direct derivative exposure to Exponent common stock.

Positive

  • None.

Negative

  • None.
Insider Pye John
Role VP Global Offices & Innovation
Type Security Shares Price Value
Grant/Award Incentive Stock Option (right to buy) 6,008 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 14,992 $0.00 --
Holdings After Transaction: Incentive Stock Option (right to buy) — 6,008 shares (Direct); Non-Qualified Stock Option (right to buy) — 14,992 shares (Direct)
Footnotes (1)
  1. The stock option becomes exercisable in four equal annual installments. Not applicable.
Incentive Stock Option size 6,008 shares Granted April 6, 2026 to VP John Pye
Non-Qualified Stock Option size 14,992 shares Granted April 6, 2026 to VP John Pye
Option exercise price $66.56 per share Exercise price for both new option grants
Incentive Option holdings after grant 6,008 options Total Incentive Stock Options following transaction
Non-Qualified Option holdings after grant 14,992 options Total Non-Qualified Stock Options following transaction
Option expiration date April 6, 2036 Expiration for both grants if unexercised
Incentive Stock Option financial
"Incentive Stock Option (right to buy) granted for 6,008 shares"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) granted for 14,992 shares"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
exercise price financial
"Both option grants carry an exercise price of $66.56 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
four equal annual installments financial
"The stock option becomes exercisable in four equal annual installments"
expiration date financial
"Options are scheduled to expire on April 6, 2036 if not exercised"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pye John

(Last)(First)(Middle)
149 COMMONWEALTH DRIVE

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP Global Offices & Innovation
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Option (right to buy)$66.5604/06/2026A6,008 (1)04/06/2036Common Stock6,008(2)6,008D
Non-Qualified Stock Option (right to buy)$66.5604/06/2026A14,992 (1)04/06/2036Common Stock14,992(2)14,992D
Explanation of Responses:
1. The stock option becomes exercisable in four equal annual installments.
2. Not applicable.
By: Wendy Whitehouse For: John Pye04/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)